We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Says Biosimilar Sponsors Should Include Reference Product on Labeling
FDA Says Biosimilar Sponsors Should Include Reference Product on Labeling
Biosimilar sponsors need to include the name of the reference product in labeling if the label includes clinical data derived from that product, the FDA said in a final guidance released Wednesday.